Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2503847, 11 pages
https://doi.org/10.1155/2017/2503847
Research Article

Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model

1School of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, Hubei 430023, China
2School of Medicine, Jianghan University, Wuhan, Hubei 430000, China
3Department of Nutrition and Food Science, Texas A&M University, College Station, TX 77843, USA

Correspondence should be addressed to Zhiguo Liu; moc.621@l_ougihz

Received 18 March 2017; Revised 2 May 2017; Accepted 14 May 2017; Published 12 June 2017

Academic Editor: Francesco Dondero

Copyright © 2017 Hualin Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Collaboration NCDRF, M. Di Cesare, J. Bentham, G. A. Stevens et al., “Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants,” The Lancet, vol. 387, no. 10026, pp. 1377–1396, 2016. View at Publisher · View at Google Scholar
  2. B. Ruiz-Núñez, L. Pruimboom, D. A. J. Dijck-Brouwer, and F. A. J. Muskiet, “Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context,” The Journal of Nutritional Biochemistry, vol. 24, no. 7, pp. 1183–1201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. V. T. Samuel and G. I. Shulman, “Mechanisms for insulin resistance: common threads and missing links,” Cell, vol. 148, no. 5, pp. 852–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. K. Erickson, “Nonalcoholic fatty liver disease,” Journal of Lipid Research, vol. 50, supplement, pp. 412–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. R. Jornayvaz and G. I. Shulman, “Diacylglycerol activation of protein kinase cepsilon and hepatic insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 574–584, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Chavez and S. A. Summers, “A ceramide-centric view of insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 585–594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lonardo, S. Ballestri, G. Marchesini, P. Angulo, and P. Loria, “Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome,” Digestive and Liver Disease, vol. 47, no. 3, pp. 181–190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. M. Anstee, G. Targher, and C. P. Day, “Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 6, pp. 330–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. W. Smith and L. A. Adams, “Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment,” Nature Reviews Endocrinology, vol. 7, no. 8, pp. 456–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Nascimbeni, R. Pais, S. Bellentani et al., “From NAFLD in clinical practice to answers from guidelines,” Journal of Hepatology, vol. 59, no. 4, pp. 859–871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Parker, N. A. Johnson, C. A. Burdon, J. S. Cohn, H. T. O'Connor, and J. George, “Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis,” Journal of Hepatology, vol. 56, no. 4, pp. 944–951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Scorletti and C. D. Byrne, “Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease,” Annual Review of Nutrition, vol. 33, pp. 231–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. B. Jump, C. M. Depner, S. Tripathy, and K. A. Lytle, “Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer,” Advances in Nutrition, vol. 6, no. 6, pp. 694–702, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Bouzianas, S. D. Bouziana, and A. I. Hatzitolios, “Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids,” Nutrition Reviews, vol. 71, no. 11, pp. 753–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shapiro, M. Tehilla, J. Attal-Singer, R. Bruck, R. Luzzatti, and P. Singer, “The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease,” Clinical Nutrition, vol. 30, no. 1, pp. 6–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. N. Serhan, “Pro-resolving lipid mediators are leads for resolution physiology,” Nature, vol. 510, no. 7503, pp. 92–101, 2014. View at Publisher · View at Google Scholar
  20. F. Yuan, H. Wang, Y. Tian et al., “Fish oil alleviated high-fat diet–induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study,” Lipids in Health and Disease, vol. 15, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  21. D. B. Jump, “N-3 polyunsaturated fatty acid regulation of hepatic gene transcription,” Current Opinion in Lipidology, vol. 19, no. 3, pp. 242–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-J. Chen, C.-C. Chen, T.-K. Li et al., “Docosahexaenoic acid suppresses the expression of FoxO and its target genes,” Journal of Nutritional Biochemistry, vol. 23, no. 12, pp. 1609–1616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Rottiers and A. M. Näär, “MicroRNAs in metabolism and metabolic disorders,” Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 239–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Panera, D. Gnani, A. Crudele, S. Ceccarelli, V. Nobili, and A. Alisi, “MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 41, pp. 15079–15086, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Google Scholar · View at Scopus
  26. A. Kozomara and S. Griffiths-Jones, “miRBase: annotating high confidence microRNAs using deep sequencing data,” Nucleic Acids Research, vol. 42, pp. D68–D73, 2013. View at Publisher · View at Google Scholar
  27. M. D. Robinson, D. J. McCarthy, and G. K. Smyth, “edgeR: a bioconductor package for differential expression analysis of digital gene expression data,” Bioinformatics, vol. 26, no. 1, pp. 139-140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Betel, M. Wilson, A. Gabow, D. S. Marks, and C. Sander, “The microRNA.org resource: targets and expression,” Nucleic Acids Research, vol. 36, no. 1, pp. D149–D153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. The Gene Ontology Consortium, “Gene ontology consortium: going forward,” Nucleic Acids Research, vol. 43, no. 1, pp. D1049–D1056, 2015. View at Publisher · View at Google Scholar
  31. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 5, p. P3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Langmead, C. Trapnell, M. Pop, and S. L. Salzberg, “Ultrafast and memory-efficient alignment of short DNA sequences to the human genome,” Genome Biology, vol. 10, no. 3, article R25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Place, L.-C. Li, D. Pookot, E. J. Noonan, and R. Dahiya, “MicroRNA-373 induces expression of genes with complementary promoter sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1608–1613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Bladé, L. Baselga-Escudero, M. J. Salvadó, and A. Arola-Arnal, “miRNAs, polyphenols, and chronic disease,” Molecular Nutrition and Food Research, vol. 57, no. 1, pp. 58–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Peng, S. Yu, H. Li, H. Xiang, J. Peng, and S. Jiang, “MicroRNAs: emerging roles in adipogenesis and obesity,” Cellular Signalling, vol. 26, no. 9, pp. 1888–1896, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Ceccarelli, N. Panera, D. Gnani, and V. Nobili, “Dual role of microRNAs in NAFLD,” International Journal of Molecular Sciences, vol. 14, no. 4, pp. 8437–8455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. E. J. Abente, M. Subramanian, V. Ramachandran, and S. H. Najafi-Shoushtari, “MicroRNAs in obesity-associated disorders,” Archives of Biochemistry and Biophysics, vol. 589, pp. 108–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Mahgoub and C. J. Steer, “MicroRNAs in the evaluation and potential treatment of liver diseases,” Journal of Clinical Medicine, vol. 5, no. 5, 2016. View at Publisher · View at Google Scholar
  40. M. B. Afonso, P. M. Rodrigues, A. L. Simão, and R. E. Castro, “Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma,” Journal of Clinical Medicine, vol. 5, no. 3, 2016. View at Publisher · View at Google Scholar
  41. N. C. Salvoza, D. C. Klinzing, J. Gopez-Cervantes, and M. O. Baclig, “Association of circulating serum MIR-34a and MIR-122 with dyslipidemia among patients with non-alcoholic fatty liver disease,” PLoS ONE, vol. 11, no. 4, article e0153497, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. V. P. Tryndyak, A. K. Marrone, J. R. Latendresse, L. Muskhelishvili, F. A. Beland, and I. P. Pogribny, “MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency,” Journal of Nutritional Biochemistry, vol. 28, pp. 83–90, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Katsura, A. Morishita, H. Iwama et al., “MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis,” International Journal of Molecular Medicine, vol. 35, no. 4, pp. 877–884, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Leti, I. Malenica, M. Doshi et al., “High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis,” Translational Research, vol. 166, no. 3, pp. 304–314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Tessitore, G. Cicciarelli, F. Del Vecchio et al., “MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice,” BMC Cancer, vol. 16, no. 1, article 3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Zhang, Y. Wang, Z. Ji, and Z. Wang, “Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease,” Gene, vol. 585, no. 1, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Mozaffarian and E. B. Rimm, “Fish intake, contaminants, and human health: evaluating the risks and the benefits,” The Journal of the American Medical Association, vol. 296, no. 15, pp. 1885–1899, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. L. H. Storlien, E. W. Kraegen, D. J. Chisholm, G. L. Ford, D. G. Bruce, and W. S. Pascoe, “Fish oil prevents insulin resistance induced by high-fat feeding in rats,” Science, vol. 237, no. 4817, pp. 885–888, 1987. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Kim, M. Okla, A. Erickson, T. Carr, S. K. Natarajan, and S. Chung, “Eicosapentaenoic acid potentiates brown thermogenesis through FFAR4-dependent up-regulation of miR-30b and miR-378,” Journal of Biological Chemistry, vol. 291, no. 39, pp. 20551–20562, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Baselga-Escudero, A. Arola-Arnal, A. Pascual-Serrano et al., “Chronic administration of proanthocyanidins or docosahexaenoic acid reversess the increase of miR-33a and miR-122 in dyslipidemic obese rats,” PLoS ONE, vol. 8, no. 7, article e69817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Daimiel-Ruiz, M. Klett-Mingo, V. Konstantinidou et al., “Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system,” Molecular Nutrition & Food Research, vol. 59, pp. 552–565, 2015. View at Google Scholar
  52. J. Gil-Zamorano, R. Martin, L. Daimiel et al., “Docosahexaenoic acid modulates the enterocyte Caco-2 cell expression of MicroRNAs involved in lipid metabolism,” Journal of Nutrition, vol. 144, no. 5, pp. 575–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. F. J. Ortega, M. I. Cardona-Alvarado, J. M. Mercader et al., “Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs,” Journal of Nutritional Biochemistry, vol. 26, no. 10, pp. 1095–1101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Zheng, Y. Ge, J. Zhang et al., “PUFA diets alter the microRNA expression profiles in an inflammation rat model,” Molecular Medicine Reports, vol. 11, no. 6, pp. 4149–4157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. K. J. Rayner, Y. Suárez, and A. Dávalos, “MiR-33 contributes to the regulation of cholesterol homeostasis,” Science, vol. 328, no. 5985, pp. 1570–1573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Kim, H. Yoon, C. M. Ramírez et al., “MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression,” Experimental Neurology, vol. 235, no. 2, pp. 476–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Lee, A. Padhye, A. Sharma et al., “A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via MicroRNA-34a inhibition,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 12604–12611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. D. T. Otway, S. Mäntele, S. Bretschneider et al., “Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic,” Diabetes, vol. 60, no. 5, pp. 1577–1581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Lambert, B. Sjouke, B. Choque, J. J. P. Kastelein, and G. K. Hovingh, “The PCSK9 decade,” Journal of Lipid Research, vol. 53, no. 12, pp. 2515–2524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. J. K. Howard and J. S. Flier, “Attenuation of leptin and insulin signaling by SOCS proteins,” Trends in Endocrinology and Metabolism, vol. 17, no. 9, pp. 365–371, 2006. View at Publisher · View at Google Scholar · View at Scopus